Nacolomab tafenatox

Nacolomab tafenatox is a mouse monoclonal antibody[1] designed for the treatment of colorectal cancer. The antibody itself, nacolomab, is fused with enterotoxin A from Staphylococcus aureus (which is reflected by 'tafenatox' in the drug's name).[1]

Schematic image of nacolomab tafenatox.
VH, VL: variable (antigen binding) domains of antibody fragment
CH1, CL: constant domains of antibody fragment
SAg: enterotoxin A (acting as a superantigen)
Nacolomab tafenatox
Monoclonal antibody
TypeFab fragment
SourceMouse
Targetcolorectal tumor antigen C242
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 NY (what is this?)  (verify)

See also

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.